That depends rather heavily on how you structure the incentives. Details are hellishly important on issues like this (but then, they always are).

My fear is that the people who make the rules will be from the part of the system that think in terms of international trade, rather than the parts of the system that think in terms of health care quality and social policy. Because, on the record, the international trade types seem to neither know nor care when their ideology imposes some regulation that is not technology- or public/private neutral.

- Jake

Friends come and go. Enemies accumulate.